bupranolol has been researched along with pindolol in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Contreras, ML; Molinoff, PB; Wolfe, BB | 1 |
Kaumann, AJ; Lemoine, H; Walter, M | 1 |
Gerstenbrand, F; Klingler, D; Poewe, W | 1 |
Brawley, L; MacDonald, A; Shaw, AM | 1 |
Horinouchi, T; Koike, K | 3 |
Doze, P; Elsinga, PH; Maas, B; Vaalburg, W; Van Waarde, A; Wegman, T | 1 |
Brahmadevara, N; MacDonald, A; Shaw, AM | 1 |
Baranowska, M; Kozłowska, H; Kozłowski, M; Malinowska, B; Schlicker, E | 1 |
1 review(s) available for bupranolol and pindolol
Article | Year |
---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
11 other study(ies) available for bupranolol and pindolol
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Kinetic analysis of the interactions of agonists and antagonists with beta adrenergic receptors.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Binding, Competitive; Bupranolol; Cell Line; Computers; Dihydroalprenolol; Kinetics; Mathematics; Pindolol; Propanolamines; Time Factors | 1986 |
Stimulant and blocking effects of optical isomers of pindolol on the sinoatrial node and trachea of guinea pig. Role of beta-adrenoceptor subtypes in the dissociation between blockade and stimulation.
Topics: Animals; Bupranolol; Cimetidine; Female; Guinea Pigs; Heart Rate; In Vitro Techniques; Isoproterenol; Kinetics; Male; Muscle Relaxation; Muscle, Smooth; Pindolol; Receptors, Adrenergic, beta; Serotonin Antagonists; Sinoatrial Node; Stereoisomerism; Trachea | 1984 |
[Therapy of essential tremor with special reference to the use of beta-blockers].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Bupranolol; Double-Blind Method; Female; Humans; Male; Metoprolol; Middle Aged; Pindolol; Prognosis; Propranolol; Sotalol; Tremor | 1982 |
Beta 1-, beta 2- and atypical beta-adrenoceptor-mediated relaxation in rat isolated aorta.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Bupranolol; Dose-Response Relationship, Drug; Imidazoles; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Norepinephrine; Pindolol; Propanolamines; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Substrate Specificity; Vasodilator Agents | 2000 |
(+/-)-Pindolol acts as a partial agonist at atypical beta-adrenoceptors in the guinea pig duodenum.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-3 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Catecholamines; Duodenum; Ethanolamines; Guinea Pigs; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta | 2001 |
Functional properties of atypical beta-adrenoceptors on the guinea pig duodenum.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alprenolol; Animals; Bupranolol; Carteolol; Clenbuterol; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Duodenum; Epinephrine; Ethanolamines; Fenoterol; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Nadolol; Norepinephrine; Phenylephrine; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Stereoisomerism | 2001 |
Partial agonistic properties of (+/-)-pindolol at atypical beta-adrenoceptors in the guinea pig gastric fundus.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Gastric Fundus; Guinea Pigs; In Vitro Techniques; Male; Pindolol; Receptors, Adrenergic, beta | 2001 |
Synthesis and evaluation of radiolabeled antagonists for imaging of beta-adrenoceptors in the brain with PET.
Topics: Adrenergic beta-Antagonists; Animals; Brain; Bupranolol; Carbazoles; Carbon Radioisotopes; Carvedilol; Fluorine Radioisotopes; Male; Models, Animal; Organ Specificity; Pindolol; Propanolamines; Propranolol; Radioligand Assay; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Tissue Distribution; Tomography, Emission-Computed | 2002 |
ALpha1-adrenoceptor antagonist properties of CGP 12177A and other beta-adrenoceptor ligands: evidence against beta(3)- or atypical beta-adrenoceptors in rat aorta.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Alprenolol; Animals; Aorta, Thoracic; Binding Sites; Bupranolol; Cell Membrane; Cerebral Cortex; Dose-Response Relationship, Drug; Ethanolamines; Imidazoles; Male; Muscle, Smooth, Vascular; Phenylephrine; Pindolol; Prazosin; Propanolamines; Propranolol; Radioligand Assay; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-3; Tritium; United Kingdom; Vasoconstriction | 2004 |
Potential involvement of a propranolol-insensitive atypical beta-adrenoceptor the vasodilator effect of cyanopindolol in the human pulmonary artery.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Bupranolol; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; In Vitro Techniques; Male; Middle Aged; Pindolol; Pulmonary Artery; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Serotonin 5-HT2 Receptor Antagonists; Vasoconstriction; Vasodilation; Vasodilator Agents | 2006 |